ARCHIVES

NTP Board Approves $4 Million Mouse Variation Concept

This article is from The Cancer Letter archive.

Vol. 11 No. 45 | November 22, 1985

Download PDF Visit The Full Archive

Related Articles

Study Finds Long-Term Remission In NHL With Tositumomab, Iodine I 131 With CHOP

December 30, 2005

In Brief: Univ. of Texas Panel Selects Four finalists for M.D. Anderson Cancer Center Presidency

April 19, 1996

FDA carries Action On Two Cancer Drugs Over To 1996

January 5, 1996

NCAB Committee Approves Recompletion Of Support Contracts

October 7, 1988

Breast Density As Important As Age In Determining Risk

September 29, 2006

Dendritic Cell Vaccine May Boost Median Survival

March 25, 2011